SARS-CoV-2 Antibody Prevalence and Association with Routine Laboratory Values in a Life Insurance Applicant Population
View ORCID ProfileSteven J. Rigatti, Robert Stout
doi: https://doi.org/10.1101/2020.09.09.20191296
Steven J. Rigatti
1Clinical Reference Laboratories, Lenexa, KS
MDRobert Stout
1Clinical Reference Laboratories, Lenexa, KS
PhD
Data Availability
Data can be obtained by contacting the authors.
Posted September 11, 2020.
SARS-CoV-2 Antibody Prevalence and Association with Routine Laboratory Values in a Life Insurance Applicant Population
Steven J. Rigatti, Robert Stout
medRxiv 2020.09.09.20191296; doi: https://doi.org/10.1101/2020.09.09.20191296
Subject Area
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3115)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13058)
- Forensic Medicine (13)
- Gastroenterology (864)
- Genetic and Genomic Medicine (4877)
- Geriatric Medicine (449)
- Health Economics (752)
- Health Informatics (3077)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (968)
- Medical Education (455)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4651)
- Nursing (247)
- Nutrition (689)
- Oncology (2398)
- Ophthalmology (681)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (308)
- Palliative Medicine (88)
- Pathology (517)
- Pediatrics (1244)
- Primary Care Research (522)
- Public and Global Health (7210)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (515)
- Toxicology (65)
- Transplantation (222)
- Urology (191)